Anthrax Toxin Lethal Factor anticorps

N° du produit ABIN1713345

Détail du produit anti-Anthrax Toxin Lethal Factor anticorps

Antigène: Anthrax Toxin Lethal Factor (Lef)

Reactivité: Bacillus anthracis

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Anthrax Toxin Lethal Factor est non-conjugé

Application: ELISA, Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)

Réactivité croisée (Details): Anthrax LF (Lethal Factor) produced by Bacillus anthracis

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from Bacillus anthracis lethal factor

Isotype: IgG

Information d'application

Indications d'application: WB 1:100-1000
IHC-P 1:100-500
IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur Anthrax Toxin Lethal Factor

Antigène: Anthrax Toxin Lethal Factor (Lef)

Autre désignation: Bacillus Anthracis Lethal Factor (Lef Produits)

Synonymes: anticorps pXO1-107, anticorps pxo1_107

Sujet:

Synonyms: Lethal factor, LF, Anthrax lethal toxin endopeptidase component, lef, pXO1-107, BXA0172, GBAA_pXO1_0172, LEF_BACAN.

Background: One of the three proteins composing the anthrax toxin, the agent which infects many mammalian species and that may cause death. LF is the lethal factor that, when associated with PA, causes death. LF is not toxic by itself. It is a protease that cleaves the N-terminal of most dual specificity mitogen-activated protein kinase kinases (MAPKKs or MAP2Ks) (except for MAP2K5). Cleavage invariably occurs within the N-terminal proline-rich region preceding the kinase domain, thus disrupting a sequence involved in directing specific protein-protein interactions necessary for the assembly of signaling complexes. There may be other cytosolic targets of LF involved in cytotoxicity. The proteasome may mediate a toxic process initiated by LF in the cell cytosol involving degradation of unidentified molecules that are essential for macrophage homeostasis. This is an early step in LeTx intoxication, but it is downstream of the cleavage by LF of MEK1 or other putative substrates. Also cleaves mouse Nlrp1b allele 1, leading to NLRP1 inflammasome activation, IL1B release and eventually host inflammatory response Miscellaneous LF binds to the heptamer formed by cleaved PA on the host cell membrane. This step is followed by internalization of the heterooligomeric complex by receptor-mediated endocytosis. LeTx requires passage through an acidic vesicle for activity, at acidic pH , as the pore is inserted into the membrane, LF is translocated and reaches its cytosolic targets. LF is probably directly involved in its routing, by interacting with the lipid membrane. This interaction could involve a conformational change of LF and/or an oligomerization of the protein. LF may have the capability of partially unfolding in order to cross the membrane. Catalytic activity Preferred amino acids around the cleavage site can be denoted BBBBxHx-|-H, in which B denotes Arg or Lys, H denotes a hydrophobic amino acid, and x is any amino acid. The only known protein substrates are mitogen-activated protein (MAP) kinase kinases. Cofactor Zn2+ Binds 1 zinc ion per subunit.

ID gène: 3361711, 39675599

UniProt: P15917